A Quantitative Assessment of Factors Affecting the Technological Development and Adoption of Companion Diagnostics

Rapid innovation in (epi)genetics and biomarker sciences is driving a new drug development and product development pathway, with the personalized medicine era dominated by biologic therapeutics and companion diagnostics. Companion diagnostics (CDx) are tests and assays that detect biomarkers and spe...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Dee, Smith, James A., Meadows, Nick A., Schuh, A., Manescu, Katie E., Bure, Kim, Davies, Benjamin, Horne, Rob, Kope, Mike, DiGiusto, David L., Brindley, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730156/
https://www.ncbi.nlm.nih.gov/pubmed/26858745
http://dx.doi.org/10.3389/fgene.2015.00357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730156/
https://www.ncbi.nlm.nih.gov/pubmed/26858745
http://dx.doi.org/10.3389/fgene.2015.00357

Ejemplares similares